Hematological toxicities and thrombosis risk associated with immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2024. [PDF]
Hou J, Mu G, Zhang Z, Xiang Q, Cui Y.
europepmc +1 more source
ABSTRACT Objective Isolated rapid eye movement sleep behavior disorder (iRBD) is a prodromal state for Lewy body disorders and exhibits biological heterogeneity that may influence clinical expression and progression. We examined clinical features in individuals with iRBD and biomarker‐defined synucleinopathy.
Daniel Weintraub +24 more
wiley +1 more source
Attention and residual mechanism-based CNN architecture (ARC-Net) with enhanced fairness generalization for deepfake facial image detection. [PDF]
Reza MS, Elias F, Mahmud MI, Ahmed N.
europepmc +1 more source
Table describing the definition of variables extracted from the National Neonatal Research Database.
T’ng Chang Kwok (22822031) +10 more
openalex +1 more source
ABSTRACT Background Collaterals are crucial factors that influence the infarct growth rate (IGR). We aimed to determine whether a comprehensive multimodal collateral score (MCS), incorporating collateral assessment at the arterial, tissue, and venous levels, is associated with functional independence and provides incremental prognostic value over ...
Giorgio Busto +12 more
wiley +1 more source
Association Between the Lactate-to-Albumin Ratio and ICU/In-Hospital Mortality in Critically Ill Patients With Comorbid Type 2 Diabetes Mellitus : A Cohort Study Utilizing the MIMIC-IV Database. [PDF]
Cheng ZT +5 more
europepmc +1 more source
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
Causes of Unfavorable Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage in Clinical Grade World Federation of Neurosurgical Societies I-III Before Aneurysm Treatment: Impact of Adverse Events. [PDF]
Baldvinsdóttir B +12 more
europepmc +1 more source

